Concepts (120)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Uterine Cervical Neoplasms | 14 | 2023 | 2020 | 2.640 |
Why?
|
Papillomavirus Infections | 10 | 2023 | 1587 | 1.640 |
Why?
|
Botswana | 19 | 2023 | 1040 | 1.160 |
Why?
|
Gynecology | 3 | 2019 | 513 | 0.990 |
Why?
|
Papillomavirus Vaccines | 4 | 2022 | 491 | 0.930 |
Why?
|
Alphapapillomavirus | 2 | 2022 | 221 | 0.800 |
Why?
|
HIV Infections | 13 | 2023 | 16718 | 0.660 |
Why?
|
Human papillomavirus 18 | 1 | 2019 | 128 | 0.660 |
Why?
|
Human papillomavirus 16 | 1 | 2019 | 262 | 0.610 |
Why?
|
Genital Neoplasms, Female | 2 | 2021 | 523 | 0.580 |
Why?
|
Early Detection of Cancer | 7 | 2023 | 3086 | 0.560 |
Why?
|
Appointments and Schedules | 2 | 2021 | 417 | 0.540 |
Why?
|
Colposcopy | 2 | 2019 | 144 | 0.530 |
Why?
|
Obstetrics | 2 | 2019 | 658 | 0.510 |
Why?
|
Pregnancy Complications, Parasitic | 1 | 2014 | 54 | 0.480 |
Why?
|
Babesiosis | 1 | 2014 | 92 | 0.450 |
Why?
|
Laboratories | 1 | 2015 | 463 | 0.410 |
Why?
|
Premature Birth | 5 | 2022 | 1721 | 0.340 |
Why?
|
Uterine Cervical Dysplasia | 2 | 2023 | 387 | 0.320 |
Why?
|
Papillomaviridae | 4 | 2022 | 1119 | 0.280 |
Why?
|
Curriculum | 1 | 2019 | 3605 | 0.270 |
Why?
|
Malaria | 1 | 2015 | 1239 | 0.270 |
Why?
|
Patient Acceptance of Health Care | 2 | 2019 | 3022 | 0.260 |
Why?
|
Hypertension, Pregnancy-Induced | 2 | 2021 | 489 | 0.230 |
Why?
|
Referral and Consultation | 1 | 2015 | 3528 | 0.210 |
Why?
|
International Cooperation | 2 | 2019 | 1420 | 0.210 |
Why?
|
Internship and Residency | 2 | 2019 | 5788 | 0.200 |
Why?
|
Stillbirth | 3 | 2022 | 346 | 0.200 |
Why?
|
Infant, Small for Gestational Age | 3 | 2021 | 440 | 0.200 |
Why?
|
Faculty, Medical | 2 | 2019 | 1181 | 0.180 |
Why?
|
Self-Examination | 1 | 2019 | 70 | 0.170 |
Why?
|
Pregnancy Outcome | 4 | 2022 | 2795 | 0.170 |
Why?
|
Vulvar Neoplasms | 1 | 2021 | 272 | 0.170 |
Why?
|
Female | 28 | 2023 | 380194 | 0.160 |
Why?
|
Quarantine | 1 | 2020 | 170 | 0.160 |
Why?
|
Cervix Uteri | 1 | 2021 | 590 | 0.150 |
Why?
|
Radiation Oncology | 1 | 2023 | 555 | 0.150 |
Why?
|
HIV | 2 | 2022 | 1604 | 0.150 |
Why?
|
Schools, Medical | 3 | 2019 | 880 | 0.150 |
Why?
|
Vaginal Smears | 1 | 2019 | 511 | 0.140 |
Why?
|
Angola | 1 | 2015 | 16 | 0.140 |
Why?
|
Organizational Objectives | 1 | 2018 | 438 | 0.140 |
Why?
|
Capacity Building | 1 | 2018 | 248 | 0.130 |
Why?
|
Adult | 15 | 2023 | 214055 | 0.130 |
Why?
|
Organizational Culture | 1 | 2019 | 510 | 0.130 |
Why?
|
Models, Organizational | 1 | 2018 | 574 | 0.130 |
Why?
|
Specimen Handling | 1 | 2019 | 694 | 0.120 |
Why?
|
Program Development | 2 | 2018 | 1316 | 0.120 |
Why?
|
Humans | 32 | 2023 | 744343 | 0.120 |
Why?
|
Triage | 1 | 2021 | 976 | 0.120 |
Why?
|
Vagina | 1 | 2019 | 825 | 0.120 |
Why?
|
Self Care | 1 | 2019 | 786 | 0.120 |
Why?
|
Prevalence | 5 | 2022 | 15226 | 0.120 |
Why?
|
Personal Satisfaction | 1 | 2017 | 643 | 0.110 |
Why?
|
Middle Aged | 11 | 2022 | 213383 | 0.110 |
Why?
|
Professional Competence | 1 | 2015 | 447 | 0.110 |
Why?
|
Hemolysis | 1 | 2014 | 420 | 0.110 |
Why?
|
National Health Programs | 1 | 2015 | 445 | 0.100 |
Why?
|
Infant Mortality | 1 | 2016 | 754 | 0.100 |
Why?
|
Pilot Projects | 3 | 2019 | 8324 | 0.100 |
Why?
|
Career Choice | 1 | 2017 | 744 | 0.100 |
Why?
|
Pregnancy Complications, Infectious | 1 | 2022 | 2026 | 0.100 |
Why?
|
Morbidity | 1 | 2016 | 1769 | 0.090 |
Why?
|
Incidence | 2 | 2021 | 20947 | 0.090 |
Why?
|
Clinical Laboratory Techniques | 1 | 2015 | 738 | 0.090 |
Why?
|
Program Evaluation | 2 | 2017 | 2488 | 0.090 |
Why?
|
Hospitals, Teaching | 1 | 2015 | 1179 | 0.090 |
Why?
|
Pregnancy | 7 | 2022 | 29144 | 0.090 |
Why?
|
Medical Oncology | 1 | 2021 | 2265 | 0.080 |
Why?
|
Prospective Studies | 4 | 2021 | 53288 | 0.080 |
Why?
|
Pregnancy Complications | 1 | 2022 | 2861 | 0.080 |
Why?
|
Survival Analysis | 2 | 2021 | 10252 | 0.070 |
Why?
|
Academic Medical Centers | 1 | 2017 | 2759 | 0.070 |
Why?
|
Education, Medical | 1 | 2018 | 1721 | 0.070 |
Why?
|
Developing Countries | 1 | 2018 | 2815 | 0.070 |
Why?
|
Vaccination | 1 | 2016 | 3278 | 0.060 |
Why?
|
Cross-Sectional Studies | 2 | 2022 | 25043 | 0.060 |
Why?
|
Cost-Benefit Analysis | 1 | 2016 | 5391 | 0.060 |
Why?
|
Pandemics | 1 | 2023 | 8388 | 0.050 |
Why?
|
Young Adult | 5 | 2022 | 56430 | 0.050 |
Why?
|
Follow-Up Studies | 2 | 2021 | 39050 | 0.050 |
Why?
|
Clinical Competence | 1 | 2017 | 4687 | 0.050 |
Why?
|
Infant, Newborn | 4 | 2022 | 25625 | 0.050 |
Why?
|
Socioeconomic Factors | 1 | 2015 | 7785 | 0.050 |
Why?
|
Mass Screening | 3 | 2022 | 5255 | 0.050 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2015 | 3923 | 0.050 |
Why?
|
Maternal Mortality | 1 | 2022 | 310 | 0.040 |
Why?
|
Time Factors | 1 | 2021 | 40075 | 0.040 |
Why?
|
Personnel Loyalty | 1 | 2017 | 10 | 0.040 |
Why?
|
Delayed Diagnosis | 1 | 2021 | 441 | 0.040 |
Why?
|
Women's Health Services | 1 | 2017 | 93 | 0.040 |
Why?
|
Adolescent | 3 | 2022 | 85781 | 0.040 |
Why?
|
Benchmarking | 1 | 2023 | 1042 | 0.040 |
Why?
|
Retrospective Studies | 2 | 2022 | 77449 | 0.030 |
Why?
|
Africa | 1 | 2018 | 673 | 0.030 |
Why?
|
Aftercare | 1 | 2022 | 866 | 0.030 |
Why?
|
Labor, Induced | 1 | 2016 | 146 | 0.030 |
Why?
|
Communicable Disease Control | 1 | 2020 | 857 | 0.030 |
Why?
|
Infant | 3 | 2021 | 35136 | 0.030 |
Why?
|
Case-Control Studies | 2 | 2021 | 21746 | 0.030 |
Why?
|
CD4 Lymphocyte Count | 1 | 2019 | 2559 | 0.030 |
Why?
|
Needs Assessment | 1 | 2018 | 1147 | 0.030 |
Why?
|
Antihypertensive Agents | 1 | 2021 | 2046 | 0.030 |
Why?
|
Anti-Retroviral Agents | 1 | 2021 | 1715 | 0.020 |
Why?
|
Biopsy | 1 | 2023 | 6756 | 0.020 |
Why?
|
United States | 1 | 2019 | 69872 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2021 | 6538 | 0.020 |
Why?
|
Interviews as Topic | 1 | 2017 | 2539 | 0.020 |
Why?
|
Child | 3 | 2022 | 77709 | 0.020 |
Why?
|
Neoplasms | 1 | 2018 | 21683 | 0.020 |
Why?
|
Rural Population | 1 | 2019 | 2210 | 0.020 |
Why?
|
Antiviral Agents | 1 | 2021 | 2987 | 0.020 |
Why?
|
Neoplasm Staging | 1 | 2021 | 11031 | 0.020 |
Why?
|
Internet | 1 | 2017 | 3064 | 0.020 |
Why?
|
Massachusetts | 1 | 2017 | 8663 | 0.020 |
Why?
|
Anti-HIV Agents | 1 | 2019 | 4256 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2016 | 15540 | 0.010 |
Why?
|
Cohort Studies | 1 | 2019 | 40561 | 0.010 |
Why?
|
Male | 2 | 2019 | 350118 | 0.010 |
Why?
|
Aged | 1 | 2021 | 163280 | 0.010 |
Why?
|
Concepts
(120)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(30)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_